Drug Trial Radar · NCT03739684
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Jun 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
208
Actual
Start
Nov 27, 2018
Primary completion
Aug 29, 2019
Study completion Aug 29, 2019
Sponsor
- Lead sponsor
- Progenics Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 14, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the diagnostic performance and safety of 18F-DCFPyL (PyL) PET/CT imaging in patients with suspected recurrence of prostate cancer who have negative or equivocal findings on conventional imaging.
Conditions
- Prostate Cancer
- Prostate Adenocarcinoma
- Prostate Cancer Recurrent
- Prostate Cancer Metastatic
Interventions
18F-DCFPyLDrug
A single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL
PET/CT ImagingDiagnostic test
PET/CT imaging will be acquired 1-2 hours post-PyL injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correct Localization Rate (CLR)Time frame: Within 60 days following 18F-DCFPyL PET/CT imaging.
Locations
14 sites in 2 countries. Site status is shown where the registry gives one.
City of Hope National Medical Center
Duarte, California
Tower Urology
Los Angeles, California
University of California San Francisco - Helen Diller Cancer Center
San Francisco, California
Stanford
Stanford, California
Yale University
New Haven, Connecticut
Moffitt Cancer Center
Tampa, Florida
University of Iowa
Iowa City, Iowa
Johns Hopkins University
Baltimore, Maryland
University of Michigan
Ann Arbor, Michigan
Washington University - Mallinckrodt Institute of Radiology
St Louis, Missouri
Memorial Sloan Kettering Cancer Center
New York, New York
University of Pennsylvania
Philadelphia, Pennsylvania
University of Wisconsin
Madison, Wisconsin
Chu de Quebec - Universite Laval
Québec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.